![\"\"](\"https:\/\/www.diex.ca\/wp-content\/uploads\/2019\/04\/hyperCORE-300x137.png\")
<\/p>\r\n<\/p>\r\n
Announcing the launch of hyperCORE International LLP<\/strong>, a Super Network of highly awarded and experienced Clinical Research Site Organizations.\u00a0 It forms the second largest site network in the world with more than 80 sites across 5 countries on 2 continents.\u00a0 Its unique ownership model combines the strengths of 8 leading independent research site companies under one umbrella focusing on agility and innovation to accelerate clinical research through centralization of core operations and innovative strategic partnerships with Sponsors\/CROs. <\/p>\r\n \u201chyperCORE is fundamentally different\u201d said Karri Venn, President, LMC Manna Research and hyperCORE founding Board member, \u201cWhile others pursue models of loosely affiliated research sites, or activation of research na\u00efve physicians and health clinics, hyperCORE builds upon the success of a tightly integrated and professional research site model already proven by its founding members.\u00a0 Further, by leveraging each members\u2019 individual successes, efficiencies are exponential and will resonate across the industry as it seeks a better path forward\u201d.\u00a0\u00a0 Venn sites former FDA commissioner Scot Gottlieb\u2019s recent call to arms for the clinical research industry to embrace desperately needed change to modernize and eliminate inefficiency in the conduct of clinical trials.<\/p>\r\n <\/p>\r\n By combining their strengths and through further integration, the alliance will be sure to turn some heads.\u00a0 At launch they will have more than 80 sites across 2 continents, spanning from Lima, Peru to Calgary, Canada \u2013 some 7,800 kilometers.<\/p>\r\n <\/p>\r\n \u201cEach of us has built successful integrated research site companies and knows first-hand the power of the integrated model.\u00a0 Now we\u2019re are taking it to the next level \u2013 creating a Super Network.\u00a0 By building on the success of each member, we will continue to aggressively add more partners and drive integration through operations and technology.\u00a0 This is an ALL-STAR team on the cutting edge as the research industry continues to evolve,\u201d said Karri Venn, President of LMC Manna Research.<\/p>\r\n <\/p>\r\n –MORE–<\/p>\r\n \u201cRight out of the gate we have a critical mass to facilitate meaningful change,\u201d said Jeff Kingsley CEO of IACT Health and Chair of the Board of Directors of hyperCORE.\u00a0 \u201cOur commitment to certified, professionalized clinical research across our membership demonstrates a commitment to quality research and patient safety,\u201d continued Kingsley, also past-Chair of the Board of Trustees of ACRP, current Board member of the Academy of Clinical Research Professionals, and a contributor to its certified clinical research professional certification program.<\/p>\r\n <\/p>\r\n hyperCORE\u2019s founding partner members are: Benchmark Research of Austin, Texas; Clinical Trials of Texas of San Antonio, Texas; DIEX Research of Montreal, Canada; FOMAT Research of San Diego, CA; IACT Health of Columbus, Georgia; LMC Manna Research of Toronto, Canada; Research Centers of America (RCA) of Hollywood, Florida and Wake Research of Raleigh, North Carolina.<\/p>\r\n <\/p>\r\n The group will be making their debut at the upcoming 2019 ACRP Conference in Nashville, TN, April 12-15th<\/sup>.\u00a0 Several of the members are nominated for awards of excellence as well as presenting at sessions during the conference.<\/p>\r\n <\/p>\r\n <\/p>\r\n About hyperCORE International:<\/strong><\/p>\r\n <\/p>\r\n Formed in 2019, hyperCORE International is a super network of highly experienced and awarded clinical research site\/network companies.\u00a0 It is an industry leader, providing Phase I-IV clinical trial services with more than 80 active research sites across the globe. It is the second largest clinical research site organization in the world.\u00a0 Its\u2019 member companies have over 100 years of combined experience and completed more than 6,000 studies helping to evaluate thousands of new drugs and treatments in more than 60,000 patients.\u00a0 Each member operates as an independent company but integrates common functions to streamline business and clinical operations through harmonization and sharing of best practices.<\/p>\r\n <\/p>\r\n hyperCORE International\u00a0is committed to the highest standard of research excellence with subject safety, data integrity, rapid study startup, competitive enrollment, and outstanding subject retention as top priorities. Its members have won numerous awards for performance, quality, and innovation.<\/p>\r\n <\/p>\r\n Learn more at http:\/\/www.hyperCOREinternational.com<\/p>\r\n <\/p>\r\n <\/p>\r\n Media Inquiries:<\/strong><\/p>\r\n <\/p>\r\n Van Johnson<\/p>\r\n 469.854.0294<\/p>\r\n vjohnson@hyperCOREintl.com<\/p>\r\n <\/p>\r\n <\/p>\r\n SOURCE HYPERCORE INTERNATIONAL<\/p>\r\n <\/p>\r\n Related Links:<\/p>\r\n http:\/\/www.hyperCOREinternational.com<\/a><\/p>\r\n <\/p>\r\n –MORE–<\/p>\r\n http:\/\/www.benchmarkresearch.net<\/a><\/p>\r\n http:\/\/www. saresearch.com<\/a><\/p>\r\n http:\/\/www.diex.ca<\/a><\/p>\r\n http:\/\/www.fomatmedical.com<\/a><\/p>\r\n http:\/\/www.iacthealth.com<\/a><\/p>\r\n http:\/\/www.lmcmannaresearch.com<\/a><\/p>\r\n
\r\n
\r\nApril 9, 2019 — Columbus, GA (PRWEB)<\/strong> \u2013 Announcing the launch of hyperCORE International LLP, a Super Network of highly awarded and experienced Clinical Research Site Organizations.\u00a0 It forms the second largest site network in the world with more than 80 sites across 5 countries on 2 continents.\u00a0 Its unique ownership model combines the strengths of 8 leading independent research site companies under one umbrella focusing on agility and innovation to accelerate clinical research through centralization of core operations and innovative strategic partnerships with Sponsors\/CROs.\u00a0 Its primary goal is to modernize the highly fragmented and inefficient research site model by assembling the industry\u2019s leading site networks under one moniker facilitating exponential efficiencies at an unprecedented scale.<\/p>\r\n
\r\n\u201cThis is the network of networks \u2013 a first of its kind,\u201d said Mark Lacy, CEO of Benchmark research and CEO of hyperCORE.\u00a0 \u201cThis is the realization of a vision several years in the making. I wanted to bring together a group of already highly successful and professionalized research site businesses in a new and powerful way.\u00a0 The magic lies within the mutual ownership model.\u00a0 This motivates and ensures we each bring the best to the table and work together in ways not possible before.\u00a0 Together, we can push the boundaries, leading the drive for further innovation, something that will resonate across the clinical research industry.\u00a0 By banding together in such an intimate and integrated way, we can accelerate the entire end to end process from feasibility to close-out.\u00a0 Its research accelerated!\u201d continued Lacy.<\/p>\r\n